MS
Mrugeshkumar Shantilal Desai
About Mrugeshkumar Shantilal Desai
Data last updated:
Mrugeshkumar Shantilal Desai is a Designated Partner at Rivon Pharmaceutical Llp (since 2018), Director at Jexcel Industries Private Limited (since 2024) and Director at Rivonex Lifescience Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Pharma, Metal & Minerals and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹14.44 Cr; the largest is Rivon Pharmaceutical Llp at ₹14.35 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rivon Pharmaceutical Llp AAL-9120 | Designated Partner | 02 Feb 2018 | 2018 | ₹14.35 Cr (FY 2024) | Active |
 Jexcel Industries Private Limited U27320GJ2024PTC153988 | Director | 31 Jul 2024 | 2024 | ₹8.3 Lakh (FY 2025) | Active |
| Rivonex Lifescience Private Limited U46497GJ2025PTC158731 | Director | 10 Feb 2025 | 2025 | Active | |
| Sanitas Human Health Private Limited U46497GJ2023PTC144130 | Director | 23 Aug 2023 | 2023 | Active | |
| Kalaya Lifescience Llp ACA-5485 | Designated Partner | 10 Apr 2023 | 2023 | Active | |
| Devpriya Realty Llp AAR-5696 | Designated Partner | 10 Jan 2020 | 2020 | Active |
Board colleagues of Mrugeshkumar Shantilal Desai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amitkumar Jayantilal Patel | 08054100 | Rivon Pharmaceutical Llp , Rivonex Lifescience Private Limited and 1 more | Designated Partner |
| Hardikkumar Manubhai Patel | 08054123 | Rivon Pharmaceutical Llp , Rivonex Lifescience Private Limited and 1 more | Designated Partner |
| Harsh H Vyas | 08054329 | Rivon Pharmaceutical Llp , Rivonex Lifescience Private Limited | Designated Partner |
| Vimarshkumar Patel Jagdishbhai | 06910758 | Rivon Pharmaceutical Llp , Rivonex Lifescience Private Limited and 1 more | Designated Partner |
| Poonam Vikas Patil | 10726300 | Jexcel Industries Private Limited | Director |
| Rishabh Lalitkumar Padhiyar | 08431394 | Kalaya Lifescience Llp | Designated Partner |
| Rohan Krishnakant Patel | 10109676 | Kalaya Lifescience Llp | Designated Partner |
| Suvas Bharatbhai Patel | 10422990 | Kalaya Lifescience Llp | Designated Partner |
| Prashantkumar Vajubhai Thakker | 08664705 | Devpriya Realty Llp | Designated Partner |
| Sagar Mahendra Mavani | 08664706 | Devpriya Realty Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mrugeshkumar Shantilal Desai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mrugeshkumar Shantilal Desai
Mrugeshkumar Shantilal Desai currently holds 6 directorships: Rivon Pharmaceutical Llp (Designated Partner, since 02 Feb 2018, revenue ₹14.35 Cr (FY 2024)); Jexcel Industries Private Limited (Director, since 31 Jul 2024, revenue ₹8.3 Lakh (FY 2025)); Rivonex Lifescience Private Limited (Director, since 10 Feb 2025); Sanitas Human Health Private Limited (Director, since 23 Aug 2023); Kalaya Lifescience Llp (Designated Partner, since 10 Apr 2023); and 1 more.
Mrugeshkumar Shantilal Desai was first appointed on 02 Feb 2018 as Designated Partner at Rivon Pharmaceutical Llp. The most recent appointment on record is 10 Feb 2025 at Rivonex Lifescience Private Limited.
The 2 current companies of Mrugeshkumar Shantilal Desai that report revenue have a combined latest revenue of ₹14.44 Cr: Rivon Pharmaceutical Llp ₹14.35 Cr (FY 2024); Jexcel Industries Private Limited ₹8.3 Lakh (FY 2025).
The current boards of Mrugeshkumar Shantilal Desai's companies include Amitkumar Jayantilal Patel (Rivon Pharmaceutical Llp), Hardikkumar Manubhai Patel (Rivon Pharmaceutical Llp), Harsh H Vyas (Rivon Pharmaceutical Llp), Vimarshkumar Patel Jagdishbhai (Rivon Pharmaceutical Llp), Poonam Vikas Patil (Jexcel Industries Private Limited), Rishabh Lalitkumar Padhiyar (Kalaya Lifescience Llp), among others.